HR 1193 United States House · 117th Congress

Cardiovascular Advances in Research and Opportunities Legacy Act

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly. The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.

Issues: ✓ Healthcare

Bill status signed all 5 stages cleared

Introduction

Feb 2021

Committee Review

Jul 2022

House Passage

Dec 2022

Senate Passage

Dec 2022

Signed into Law

Dec 2022

Introduced Feb 22, 2021 Signed Dec 20, 2022

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Dec 20, 2022

Signed into law

Signed by President.

executive

Dec 5, 2022

Introduced

On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H8755)

lower

Dec 5, 2022

Lower · Passed

Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.

lower

Dec 5, 2022

Introduced

DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1193.

lower

Dec 5, 2022

Introduced

Mr. Pallone moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H8755-8756)

lower

Dec 1, 2022

Upper · Passed

Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S6947)

upper

Dec 1, 2022

Upper · Passed

Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S6947)

upper

Jul 12, 2022

Upper · Passed

Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.

upper

Jun 14, 2022

Upper · Passed

Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

upper

May 25, 2022

Committee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

upper

Dec 8, 2021

Introduced

The title of the measure was amended. Agreed to without objection.

lower

Dec 8, 2021

Introduced

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7518)

lower

Dec 8, 2021

Lower · Passed

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7518)

lower

Dec 8, 2021

Introduced

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

lower

Dec 8, 2021

Lower · Passed

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-212.

lower

Nov 17, 2021

Introduced

Ordered to be Reported (Amended) by Voice Vote.

lower

Nov 17, 2021

Lower · Passed

Committee Consideration and Mark-up Session Held.

lower

Nov 4, 2021

Lower · Passed

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

lower

Nov 4, 2021

Lower · Passed

Subcommittee Consideration and Mark-up Session Held.

lower

Feb 23, 2021

Committee

Referred to the Subcommittee on Health.

lower

Feb 22, 2021

Committee

Referred to the House Committee on Energy and Commerce.

lower

Feb 22, 2021

Introduced

Introduced in House

lower

1 primary · 183 co-sponsors